Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/29/2010 | CN101928274A Peperphentonamine derivative |
12/29/2010 | CN101928265A 1-(cinnamoyl)-4-alkyl amide piperazine compound and preparation method thereof |
12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
12/29/2010 | CN101928259A 2-arylthiazole derivative and medicament composition thereof |
12/29/2010 | CN101928244A Structural analogue and derivative of isochromanone-4 compound with cardiovascular activity, preparation method and application thereof |
12/29/2010 | CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them |
12/29/2010 | CN101928240A Leonurine analog and preparation method thereof |
12/29/2010 | CN101928234A 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same |
12/29/2010 | CN101928226A N-(2-ethoxy) feriilamidoethyl nitrate compound and preparation method thereof |
12/29/2010 | CN101926997A Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
12/29/2010 | CN101926985A Lumbrokinase injection for treating thromboembolic disease |
12/29/2010 | CN101926981A Methods of treating neurological conditions with hematopoietic growth factors |
12/29/2010 | CN101926976A Pill for treating angiitis |
12/29/2010 | CN101926959A Chinese medicinal herbal preparation for preventing and treating stroke, adjusting blood fat and relaxing bowels |
12/29/2010 | CN101926925A Natural mineral haemorrhoids and eczema ointment |
12/29/2010 | CN101926922A Chinese patent medicament for treating cerebrovascular diseases and preparation method thereof |
12/29/2010 | CN101926892A Medicament for treating brain stroke |
12/29/2010 | CN101926869A Medicament for treating dizziness and headache and preparation method thereof |
12/29/2010 | CN101926868A External traditional Chinese medicine for preventing and treating phlebitis caused by chemotherapeutic medicines |
12/29/2010 | CN101926859A Chinese medicinal composition |
12/29/2010 | CN101926849A Method for preparing compound salvia composition for treating heart cerebrovascular disease |
12/29/2010 | CN101926848A Medicinal composition for treating heart cerebrovascular diseases and preparation thereof |
12/29/2010 | CN101926845A Application of medicinal composition in preparation of medicament for treating coronary heart disease |
12/29/2010 | CN101926843A Quality control method of Xinnaoqing soft capsules |
12/29/2010 | CN101926841A Total flavonoids of herba lycopi in botanical medicine for treating cardiovascular disease and preparation method thereof |
12/29/2010 | CN101926836A Pubescent holly root preparation for treating heart cerebrovascular diseases |
12/29/2010 | CN101926835A Method for extracting gingko total terpene lactones and injection containing same |
12/29/2010 | CN101926802A Application of quinazoline compounds |
12/29/2010 | CN101926800A Pharmaceutical composition containing amrinone and preparation method and application thereof |
12/29/2010 | CN101926798A Dispersible tablet containing amlodipine and valsartan |
12/29/2010 | CN101926793A Combined medicament containing telmisartan and aliskiren and preparation method thereof |
12/29/2010 | CN101926788A Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof |
12/29/2010 | CN101926787A Application of flavone compound in protecting liver |
12/29/2010 | CN101926763A Method for preparing lipoalprostadil sterile preparation |
12/29/2010 | CN101926505A Caffeine electronic cigarette liquid |
12/29/2010 | CN101559043B Benzene sulfonic acid levo-amlodipine pill and preparation method thereof |
12/29/2010 | CN101543599B Medicine for curing hypertension and preparation method thereof |
12/29/2010 | CN101531629B Method for preparing levamlodipine from racemic amlodipine maleate |
12/29/2010 | CN101503392B Aromatic aminomethane compounds, as well as preparation and medical use thereof |
12/29/2010 | CN101455796B Prescription for treating faint |
12/29/2010 | CN101450126B Formula for treating lower-limb deep veins thrombus |
12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
12/29/2010 | CN101417132B Use of medicine combination comprising carvedilol and angiotensin II recipient antagonist in preparing medicine for treating kidney disease |
12/29/2010 | CN101417082B Traditional Chinese medicine combination for treating rheumatic heart disease |
12/29/2010 | CN101401930B Polypeptide and uses in preparing anti-heart failure and anti-inflammatory reaction medicament |
12/29/2010 | CN101396468B Traditional Chinese medicine for treating diabetes coronary heart disease |
12/29/2010 | CN101301454B Navel plaster with powder for soothing heart |
12/29/2010 | CN101301398B Chinese medicine for treating hypertension |
12/29/2010 | CN101214270B Acanthopanax senticosus effective fraction extract, preparation and application thereof |
12/29/2010 | CN101209288B Corydalis decumbentis orally disintegrating tablets |
12/29/2010 | CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
12/29/2010 | CN101200465B Decahydronaphthalene compounds and medical uses thereof |
12/29/2010 | CN101190289B Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain |
12/29/2010 | CN101181333B Chinese medicine injection for curing cardiovascular and cerebrovascular diseases as well as method for manufacture and detection thereof |
12/29/2010 | CN101125198B Application of HSP27 in aspect for improving post-ischemic cardiac systolic function |
12/29/2010 | CN101098702B Drugs, food or drink for improving pancreatic functions |
12/29/2010 | CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
12/29/2010 | CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof |
12/29/2010 | CA2766048A1 Novel acetylsalicylic acid salts |
12/29/2010 | CA2765697A1 Diffusion enhancing compounds and their use alone or with thrombolytics |
12/29/2010 | CA2765462A1 Mexiletine amino acid and peptide prodrugs and uses thereof |
12/29/2010 | CA2764597A1 Therapeutic drug for hypertension or high-normal blood pressure |
12/29/2010 | CA2764475A1 Crystals |
12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
12/28/2010 | US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage |
12/28/2010 | US7858655 synergistic mixtures reduce damage to neurons after a neurodegenerative insult; time-release agents; antiischemic agents; amyotrophic lateral slerosis (ALS), Alzheimer's disease, Parkinson's disease, Hunntington's disease, multiple sclerosis |
12/28/2010 | US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
12/28/2010 | US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes |
12/28/2010 | US7858626 Pyrimidineamines as angiogenesis modulators |
12/28/2010 | US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme |
12/28/2010 | US7858615 (S)-(-)-1-(4-fluoroisoquinolin-5-Yl)Sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate |
12/28/2010 | US7858597 formulations of ANGIOTENSIN II AT1 receptors antagonists, using the cyclodextrins or their derivatives, lipossomes and the biodegradable polymers; increasing the bio-availability of losartan |
12/28/2010 | US7858584 Angiogenically effective unit dose of FGF and method of administering |
12/28/2010 | US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2 |
12/28/2010 | US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
12/28/2010 | US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
12/26/2010 | CA2707647A1 Novel 2-mercaptocyclopentanecarboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
12/23/2010 | WO2010148396A1 Perindopril tosylate |
12/23/2010 | WO2010148042A1 Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb) |
12/23/2010 | WO2010148013A2 Lipid formulated dsrna targeting the pcsk9 gene |
12/23/2010 | WO2010147234A1 Diarylamide-spirodiamine derivative |
12/23/2010 | WO2010147171A1 Chicken-derived anti-lox-1 antibody |
12/23/2010 | WO2010147133A1 Novel imidazopyridine compound |
12/23/2010 | WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor |
12/23/2010 | WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof |
12/23/2010 | WO2010146881A1 Substituted isoquinoline derivative |
12/23/2010 | WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor |
12/23/2010 | WO2010146407A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
12/23/2010 | WO2010146351A1 Indolylmethyl-morpholine derivatives as kinase inhibitors |
12/23/2010 | WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators |
12/23/2010 | WO2010146236A1 Urea substituted sulphonamide derivatives |
12/23/2010 | WO2010146187A2 Process for the preparation of telmisartan |
12/23/2010 | WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof |
12/23/2010 | WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof |
12/23/2010 | WO2010144959A1 Analogues of anti-fibrotic agents |
12/23/2010 | WO2010119161A3 Antiepileptic, hypocholesterolemic and neuroprotective compound |
12/23/2010 | WO2010088450A3 Arylamide derivatives useful in the treatment of diseases associated with serca activity |
12/23/2010 | WO2009150535A8 Dronedarone for the prevention of permanent atrial fibrillation |
12/23/2010 | US20100324274 Novel synthetic ganglioside derivatives and compositions thereof |
12/23/2010 | US20100324150 Hyperbranched polyglycerol for improving heart function |